| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $288.9M | -67.3% |
| Cost of Revenue | $148.7M | -12.0% |
| R&D Expense | $17.3M | -5.9% |
| SG&A Expense | $151.4M | +17.1% |
| Operating Income | -$31.6M | -105.5% |
| Interest Expense | $45.9M | +124.8% |
| Pre-tax Income | $617.7M | +12.0% |
| Income Tax | $756.1M | +1143.4% |
| Net Income | -$119.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $575.0M | -9.0% |
| Accounts Receivable | $54.6M | -60.6% |
| Inventory | $51.4M | +19.1% |
| Current Assets | $699.9M | -17.5% |
| Total Assets | $1.49B | -34.8% |
| Current Liabilities | $87.5M | -20.6% |
| Long-term Debt | $524.1M | -0.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $126.2M | -76.4% |
| Capital Expenditures | $65.6M | +283.6% |
| Investing Cash Flow | -$122.3M | +54.3% |
| Financing Cash Flow | -$61.1M | +67.4% |
| Free Cash Flow | $60.7M | -88.3% |
| -154.1% |
| EPS (Basic) | -$0.90 | -153.9% |
| EPS (Diluted) | -$0.90 | -153.9% |
| Total Liabilities |
| $697.6M |
| -49.3% |
| Stockholders' Equity | $416.8M | -23.6% |